FDA

4 stories tagged FDA on Learning Fanatic.

Update: FDA approves Inovio's Voceryq for a rare airway disease The FDA granted accelerated approval to Inovio's DNA immunotherapy Voceryq on 30 October 2026; 7 of 26 patients needed no surgery in a year.
US lets pharmacies compound six unapproved peptides HHS says it will not act against licensed pharmacies and physicians that compound six unapproved peptides, including BPC-157, under an interim policy.
Upcoming: FDA decision due today on Inovio's INO-3107 The FDA's target date to decide on Inovio's DNA therapy INO-3107 for a rare airway disease is 30 October 2026. No outcome has been reported yet.
FDA approves Hibsago, first antisense drug for hepatitis B The FDA approved GSK's Hibsago (bepirovirsen) on 20 October 2026 as an add-on for chronic hepatitis B; about 19% reached functional cure in trials.